TG Therapeutics remains a Strong Buy as BRIUMVI drives robust revenue growth and pipeline expansions. Learn more about TGTX ...

Korea approves Keytruda SC, slashing treatment time to 2 minutes Alteogens ALT-B4 enables faster subcutaneous Keytruda launch ...

Tecentriq SC, launched in India by the pharma giant Roche, is subcutaneous. This means it is injected directly under the skin ...

Roche was granted a Phase 3 clinical trial waiver by CDSCO last year for the Indian launch of Tecentriq SC. The Swiss pharma giant is committed to conducting a post-market study in India.

Around 80,000 lung cancer patients are diagnosed in India each year, the majority at advanced stages of the disease.

Though the Tecentriq SC has created buzz, oncologists say it is not about speed. It reflects how cancer care is evolving from ...

New Delhi, May 14 (PTI) Swiss pharma major Roche on Thursday announced the launch of its atezolizumab injection, Tecentriq SC that is administered under the skin for lung cancer treatment, in India ...

Approved by the Drugs Controller General of India around two months ago for adjuvant and metastatic non-small cell lung cancer, Tecentriq SC is now available across India with more than 100 patients ...

Roche launches Tecentriq SC, a quick lung cancer treatment injection in India, reducing administration time and improving patient experience.

Tecentriq SC, also known as the '7-minute cancer shot', promises to make treatment significantly faster and more convenient ...

Huons Global's Second Technovalley headquarters building/Courtesy of Huons As shareholder backlash spread over the merger of Huons Lab, Huons Group decided to set up a venue to communicate directly ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...